Investing Ideas
/
Singaporean Pharmaceuticals & Biotech High Insider Buying

Singaporean Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

1 companies

Hyphens Pharma International

Market Cap: S$106.6m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

1J5

S$0.35

6.1%

12.9%